BioPharma Credit PLC (OTCMKTS:BOPCF) Short Interest Update

BioPharma Credit PLC (OTCMKTS:BOPCF) was the target of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 42 shares, an increase of 200.0% from the January 15th total of 14 shares. Based on an average daily volume of 10,455 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 10,455 shares, the days-to-cover ratio is presently 0.0 days.

BioPharma Credit Price Performance

BioPharma Credit stock opened at $0.87 on Thursday. The firm has a 50-day moving average of $0.87 and a two-hundred day moving average of $0.90. BioPharma Credit has a 1 year low of $0.78 and a 1 year high of $0.95.

BioPharma Credit Company Profile

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.